Furthermore, immunohistochemistry showed that p53 was upregulated while UBE2M was downregulated in tumor sections from the mice implanted by UBE2M d-pleted HepG2 cells compared to untreated control group (Figure 7E). This evidence concerns the gene TP53 and neoplasm.